STATUTORY RULES.
1958. No. 23.
REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1957.*
I THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1957.
Dated this twenty-seventh
day of March , 1958.
Governor-General.
By His Excellency’s Command,
Minister of State for Health.
Amendments of the National Health (Pharmaceutical Benefits) Regulations.†
Commencement.
1. These Regulations shall come into operation on the first day of April, 1958.
Pharmaceutical benefits for specified diseases or purposes.
2. Regulation 11 of the National Health (Pharmaceutical Benefits) Regulations is amended by omitting sub-regulation (2.) and inserting in its stead the following sub-regulation:—
“(2.) A medical practitioner may, in respect of a pensioner, prescribe a general pharmaceutical benefit the name or formula of which is specified in item 16, 37, 48, 49, 50, 51 or 53 in the Second Schedule for the treatment of any disease from which the pensioner is suffering.”.
Writing of prescription.
3. Regulation 17 of the National Health (Pharmaceutical Benefits) Regulations is amended—
(a) by omitting sub-regulation (3.) and inserting in its stead the following sub-regulation:—
“(3.) For the purposes of paragraph (d) of the last preceding sub-regulation, a prescription for the supply of two or more strengths of a form of a general pharmaceutical benefit the name or formula of which is specified in item 10, 14, 21, 111 or 136 in the First Schedule shall be deemed to prescribe one general pharmaceutical benefit.”; and
(b) by omitting from sub-regulation (4.) the words “the general pharmaceutical benefit Cortisone Acetate, Hydrocortisone, Prednisolone or Prednisone” and inserting in their stead the words and figures “a general pharmaceutical benefit the name or formula of which is specified in item 12, 23, 24, 41, 42, 43 or 44 in the Second Schedule”..
* Notified in the Commonwealth Gazette on 31st March 1958.
† Statutory Rules 1956, No. 54, as amended by Statutory Rules 1956, No. 75; and 1957, Nos. 25 and 52.
1643/55.—Price 9d. 9/20.3.1958.
Prescriptions of benefits in excessive quantities or for persons not entitled.
4. Regulation 19 of the National Health (Pharmaceutical Benefits) Regulations is amended—
(a) by omitting from paragraph (a) of sub-regulation (1.) the words “may be prescribed as a pharmaceutical benefit only for the treatment of a disease specified” and inserting in their stead the words “,at the time when the prescription was written, could be prescribed as a pharmaceutical benefit only for the treatment of a disease specified at that time”; and
(b) by omitting from sub-regulation (1.) the words “an amount equal to” and inserting in their stead the words “such amount (if any) as is determined by the Minister, being an amount not exceeding”.
Supply of pharmaceutical benefits on prescriptions.
5. Regulation 20 of the National Health (Pharmaceutical Benefits) Regulations is amended by omitting from sub-regulation (2.) the words “Cortisone Acetate, Hydrocortisone, Prednisolone or Prednisone as a pharmaceutical benefit” and inserting in their stead the words and figures “a general pharmaceutical benefit the name or formula of which is specified in item 12, 23, 24, 41, 42, 43 or 44 in the Second Schedule”.
Supply of pharmaceutical benefit before surrender of written prescription.
6. Regulation 21 of the National Health (Pharmaceutical Benefits) Regulations is amended—
(a) by omitting from sub-regulation (2.) the words “The pharmaceutical benefit Cortisone Acetate, Hydrocortisone, Prednisolone or Prednisone” and inserting in their stead the words and figures “A pharmaceutical benefit the name or formula of which is specified in item 12, 23, 24, 41, 42, 43 or 44 in the Second Schedule”; and
(b) by omitting from sub-regulation (4.) the words “Cortisone Acetate, Hydrocortisone, Prednisolone or Prednisone as a pharmaceutical benefit” and inserting in their stead the words and figures “a general pharmaceutical benefit the name or formula of which is specified in item 12, 23, 24, 41, 42, 43 or 44 in the Second Schedule”.
First Schedule.
7. The First Schedule to the National Health (Pharmaceutical Benefits) Regulations is repealed and the following Schedule inserted in its stead:—
First Schedule.
Regulation 10.
DRUGS AND MEDICINAL PREPARATIONS THAT MAY BE PRESCRIBED FOR SUPPLY, SUPPLIED AND RECEIVED AS GENERAL PHARMACEUTICAL BENEFITS.
Item No. | Name or Formula. |
1 | Acetarsol Soluble |
2 | Acetazolamide |
3 | Adrenalin in Oil |
4 | Adrenalin Tartrate |
5 | Aloxidone |
6 | Amidone |
7 | Amyl Nitrite |
8 | Antazoline |
9 | Atropine Sulphate |
10 | Aurothioglucose Oily |
First Schedule—continued.
Item No. | Name or Formula. |
11 | Benzathine Penicillin with Procaine Penicillin and Potassium Penicillin |
12 | Benzhexol Hydrochloride |
13 | Bismuth Glycollylarsanilate |
14 | Calcium Aurothiomalate |
15 | Calf Lymph |
16 | Carbachol |
17 | Carbarsone |
18 | Carbimazole |
19 | Chiniofon |
20 | Chlormerodrin |
21 | Cholera Vaccine |
22 | Dapsone |
23 | Darrow’s Solution |
24 | Desacetyl-Lanatoside C |
25 | Dextrose Aqueous |
26 | Dextrose in 1/5 Normal Saline |
27 | Dextrose in Ringer’s Solution |
28 | Diethazine Hydrochloride |
29 | Diethylcarbamazine |
30 | Digitalis |
31 | Digitoxin |
32 | Digoxin |
33 | Dihydroergotamine |
34 | Dihydromorphinone |
35 | Diiodohydroxyquinoline |
36 | Dimercaprol |
37 | Diphenhydramine Hydrochloride |
38 | Diphtheria and Tetanus Toxoids Combined |
39 | Diphtheria Antitoxin |
40 | Diphtheria Pertussis Antigen |
41 | Diphtheria Pertussis and Tetanus Antigen |
42 | Diphtheria Prophylactic (Formalinized Toxoid) |
43 | Diphtheria Prophylactic (Purified Toxoid Aluminium Phosphate) |
44 | Diphtheria Toxoid Purified (diluted for skin test only) |
45 | Emetine Hydrochloride |
46 | Emetine Bismuth Iodide |
47 | Entero-Vioform |
48 | Ephedrine Hydrochloride |
49 | Ephedrine Sulphate |
50 | Ergometrine Maleate |
51 | Ergotamine Tartrate |
52 | Ethopropazine Hydrochloride |
53 | Ethoxzolamide |
54 | Ethyl Biscoumacetate |
55 | Ethylidene Dicoumarin |
56 | Gas Gangrene Antitoxin (Oedematiens) |
57 | Gas Gangrene Antitoxin (Perfringens) |
58 | Gas Gangrene Antitoxin (Polyvalent) |
59 | Gas Gangrene Antitoxin (Septique) |
60 | Glyceryl Trinitrate |
61 | Hartmann’s Solution |
62 | Hartmann’s Solution with Dextrose |
63 | Heparin |
64 | Heparin Retard |
65 | Hexamethonium Bromide |
66 | Hexamethonium Bromide with Ephedrine |
67 | Hexamethonium Tartrate |
68 | Hyaluronidase |
69 | Hyoscine Hydrobromide |
70 | Insulin |
71 | Insulin Globin Zinc |
72 | Insulin Isophane |
First Schedule—continued.
Item No. | Name or Formula. |
73 | Insulin (Special P) |
74 | Insulin Protamine Zinc |
75 | Insulin Zinc |
76 | Isoprenaline Hydrochloride |
77 | Isoprenaline Sulphate |
78 | Leptazol |
79 | Mecamylamine |
80 | Mecholyl Chloride |
81 | Mepacrine Hydrochloride |
82 | Mepyramine Maleate |
83 | Mercaptomerin Sodium |
84 | Mercuramide with Theophylline |
85 | Mersalyl |
86 | Methoin |
87 | Methyl Atropine Nitrate |
88 | Methylergometrine Tartrate |
89 | Morphine Sulphate |
90 | Morphine with Atropine |
91 | Morphine with Hyoscine |
92 | Nalorphine Hydrobromide |
93 | Neoarsphenamine |
94 | Neostigmine Bromide |
95 | Neostigmine Methylsulphate |
96 | Nikethamide |
97 | Noradrenaline |
98 | Ouabain |
99 | Oxytocin |
100 | Pamaquin |
101 | Papaveretum |
102 | Papaveretum with Hyoscine Hydrobromide |
103 | Papaverine Hydrochloride |
104 | Paramethadione |
105 | Penicillin |
106 | Penicillin, Procaine |
107 | Pentaerythritol Tetranitrate |
108 | Pentolinium Tartrate |
109 | Pentolinium Tartrate with Ephedrine |
110 | Pertussis Prophylactic (Haemagglutinin Aluminium Phosphate Adsorbed) |
111 | Pertussis Vaccine (Phase 1) |
112 | Pethidine Hydrochloride |
113 | Pethidine Scopolamine |
114 | Phemitone |
115 | Phenobarbitone Sodium |
116 | Phenoxymethyl Penicillin |
117 | Phensuximide |
118 | Phenindione |
119 | Phenytoin Sodium |
120 | Phthalylsulphacetamide |
121 | Phthalylsulphathiazole |
122 | Picrotoxin |
123 | Pitressin Tannate in Oil |
124 | Primaquine Diphosphate |
125 | Primidone |
126 | Procainamide Hydrochloride |
127 | Procaine Hydrochloride in Normal Saline |
128 | Procyclidine Hydrochloride |
129 | Proguanil Hydrochloride |
130 | Promethazine Hydrochloride |
131 | Prophenpyridamine Para-Aminosalicylate |
132 | Protamine Sulphate |
133 | Pyridoxine Hydrochloride |
134 | Quinidine Sulphate |
First Schedule—continued.
Item No. | Name or Formula. |
135 | Ringer’s Solution |
136 | Sodium Aurothiomalate |
137 | Sodium Calciumedetate |
138 | Sodium Chloride |
139 | Sodium Chloride with Dextrose |
140 | Sodium Lactate |
141 | Sodium Sulphate |
142 | Succinylsulphathiazole |
143 | Sulphadiazine |
144 | Sulphadiazine Sodium |
145 | Sulphadimidine |
146 | Sulphadimidine Sodium |
147 | Sulphafurazole |
148 | Sulphaguanidine |
149 | Sulphamerazine |
150 | Sulphamethizole |
151 | Sulphamethoxypyridazine |
152 | Sulphapyridine |
153 | Sulphathiazole |
154 | Sulphonamides, Mixed (A): Two Sulphonamides |
155 | Sulphonamides, Mixed (B): Three Sulphonamides |
156 | Sulphonamides, Mixed (C): Four Sulphonamides |
157 | Syntocinon |
158 | T.A.B. Vaccine (Anti-Typhoid-Para-Typhoid) |
159 | Tetanus Antitoxin |
160 | Tetanus Toxoid (Formalinized) |
161 | Tetanus Toxoid (Purified Aluminium Phosphate Adsorbed) |
162 | Theophylline with Ethylenediamine |
163 | Thiacetazone |
164 | Thiouracil, Methyl |
165 | Thiouracil, Propyl |
166 | Thyroid |
167 | Tiger Snake Anti-Venene |
168 | Triethanolamine Trinitrate |
169 | Troxidone |
170 | Vasopressin |
171 | Vitamin K |
172 | Water for Injection |
Second Schedule.
8. The Second Schedule to the National Health (Pharmaceutical Benefits) Regulations is repealed and the following Schedule inserted in its stead:—
Second Schedule.
Regulation 11.
DRUGS AND MEDICINAL PREPARATIONS THAT MAY BE PRESCRIBED FOR SUPPLY, SUPPLIED AND RECEIVED AS GENERAL PHARMACEUTICAL BENEFITS ONLY FOR THE TREATMENT OF A DISEASE OR PURPOSE.
Item No. | Name or Formula. | Disease or Purpose. |
1 | Amodiaquine ............... | Malaria |
|
| Amoebiasis |
|
| Lupus erythematosus |
2 | Bemegride with Amiphenazole Hydrochloride | Antidote for barbiturate and other hypnotic poisons |
3 | Busulphan ................. | The leukaemias |
4 | Calcium Benzoyl Para-Aminosalicylate (B-Pas) | Tuberculosis |
Second Schedule—continued.
Item No. | Name or Formula. | Disease or Purpose. |
5 | Calcium Para-Aminosalicylate | Tuberculosis |
6 | Caramiphen Hydrochloride ..... | Parkinsonism |
7 | Chlorambucil .............. | Malignant lymphoma and related conditions |
8 | Chloramphenicol ............ | Acute laryngo-tracheo-bronchitis |
|
| As an alternative to penicillin in the treatment of any disease in a person in whom penicillin sensitivity has been established |
|
| Bacillary dysentery that is resistant both to sulphonamides and streptomycin |
|
| Bacterium coli meningitis if other forms of treatment are unsuccessful |
|
| Brucellosis |
|
| Granuloma inguinale |
|
| Infections due to Friedlander bacillus |
|
| Infections due to haemophilus influenzae |
|
| Lymphogranuloma venereum |
|
| Salmonella infections |
|
| Severe gastro-enteritis in children |
|
| Staphylococcal infections |
|
| Surgical conditions of the bowel (pre-operative and post-operative) |
|
| Typhoid fever |
|
| Typhus and other rickettsial diseases |
|
| Urinary tract infections due to gram negative bacilli that do not respond to sulphonamides |
|
| Whooping cough (haemophilus pertussis) |
9 | Chloramphenicol Palmitate ..... | Any disease or purpose specified in this column in relation to chloramphenicol |
10 | Chloroquine Base ........... | Malaria |
|
| Amoebiasis |
|
| Lupus erythematosus |
11 | Chlortetracycline ............ | Actinomycosis |
|
| Acute and sub-acute bacterial endocarditis-streptococcus faecalis |
|
| Amoebiasis |
|
| As an alternative to penicillin in the treatment of any disease in a person in whom penicillin sensitivity has been established |
|
| Bacillary dysentery that is resistant both to sulphonamides and streptomycin |
|
| Brucellosis |
|
| Chancroid |
|
| Granuloma inguinale |
|
| Infections due to Friedlander bacillus |
|
| Leptospirosis |
|
| Lymphogranuloma venereum |
|
| Pneumonia that does not respond to penicillin or sulphonamides |
|
| Primary atypical pneumonia |
|
| Psittacosis |
|
| Puerperal infections |
|
| Rat-bite fever—spirillum minus |
|
| Staphylococcal infections |
|
| Trachoma that does not respond to sulphonamides |
|
| Typhus and other rickettsial diseases |
|
| Urinary tract infections due to gram negative bacilli that do not respond to sulphonamides |
|
| Whooping couth (haemophilus pertussis) |
|
| Mucoviscidosis |
Second Schedule—continued.
Item No. | Name or Formula. | Disease or Purpose. |
12 | Cortisone Acetate ............ | Acquired haemolytic anaemia |
|
| Acute exfoliative dermatitis associated with drug therapy |
|
| Acute rheumatic carditis |
|
| Addison’s disease and other forms of adrenocortical hypoplasia |
|
| Adrenogenital syndrome |
|
| Dermatomyositis |
|
| Panhypopituitarism |
|
| Pemphigus |
|
| Periarteritis nodosa |
|
| Pseudohermaphroditism |
|
| Sarcoidosis |
|
| Scleroderma |
|
| Status asthmaticus |
|
| Systemic lupus erythematosus |
|
| The leukaemias |
|
| Thrombocytopenic purpura |
|
| Total adrenalectomy |
|
| Still’s disease in children under the age of 16 years |
|
| Ulcerative colitis proven by sigmoidoscopy and radiological report |
|
| Henoch’s purpura |
|
| Posterior uveitis |
|
| Sympathetic ophthalmitis |
13 | Cyanocobalamin (strengths other than 1,000 microgramme strength) | Established megalocytic anaemias |
14 | Cyanocobalamin (1,000 micro-gramme strength) | Neuroblastoma |
15 | Deoxycortone Acetate ......... | Addison’s disease |
16 | Dienoestrol ................ | Carcinoma of the prostate |
|
| Mammary carcinoma |
17 | Dihydrostreptomycin .......... | Any disease or purpose specified in this column in relation to streptomycin, but only if the person being treated for that disease or purpose is allergic to streptomycin |
18 | Dihydrotachysterol ........... | Parathyroid deficiency |
19 | Erythromycin ............... | Staphylococcal infections that are resistant both to the tetracyclines and to penicillin |
20 | Erythromycin Lactobionate | Any disease or purpose specified in this column in relation to erythromycin |
21 | Erythromycin Stearate ......... | The treatment of children under the age of 16 years in respect of any disease or purpose specified in this column in relation to erythromycin |
22 | Folic Acid ................. | Sprue or the sprue-like syndrome Macrocytic anaemia |
23 | Hydrocortisone ............. | Any disease or purpose specified in this column in relation to cortisone acetate |
24 | Hydrocortisone Sodium Succinate .. | Acute adrenal failure due to a medical or surgical crisis |
25 | Isoniazid .................. | Leprosy |
|
| Tuberculosis |
26 | Mercaptopurine ............. | The leukaemias |
27 | Methorphinan .............. | Inoperable cancer |
28 | Mustine Hydrochloride .. | Malignant lymphoma and related conditions |
29 | Nitrofurantoin .............. | Urinary tract infections |
30 | Nitromin .................. | Malignant lymphoma and related conditions |
31 | Nystatin .................. | Proven monilia infections |
Second Schedule—continued.
Item No. | Name or Formula. | Disease or Purpose. |
32 | Nystatin (Suspension of) ....... | The treatment of children under the age of 16 years in respect of any disease or purpose specified in this column in relation to nystatin |
33 | Oxytetracycline Dihydrate ...... | Any disease or purpose specified in this column in relation to chlortetracycline |
34 | Oxytetracycline Hydrochloride | Any disease or purpose specified in this column in relation to chlortetracycline |
35 | Pancreatin ................. | Fibrocystic disease of the pancreas |
|
| Pancreatico-duodenectomy |
36 | Para-Aminosalicylic Acid ....... | Tuberculosis |
37 | Penicillin .................. | For the penicillin treatment of haemophiliacs |
|
| Nephritis in children under the age of 16 years |
|
| Prophylactic use in rheumatic fever or chorea in children under the age of 16 years |
38 | Penicillin with Streptomycin ..... | Endocarditis due to streptococcus faecalis |
|
| Endocarditis due to streptococcus viridans |
39 | Phenoxymethyl Penicillin ....... | Any disease or purpose specified in this column in relation to penicillin |
40 | Phenindamine Tartrate ......... | Parkinsonism |
41 | Prednisolone ............... | Any disease or purpose specified in this column in relation to cortisone acetate |
42 | Prednisolone with Magnesium Trisilicate and Aluminium Hydroxide | Any disease or purpose specified in this column in relation to cortisone acetate |
43 | Prednisone ................. | Any disease or purpose specified in this column in relation to cortisone acetate |
44 | Prednisone with Magnesium | Any disease or purpose specified in this column |
| Trisilicate and Aluminium Hydroxide | in relation to cortisone acetate |
45 | Progesterone ............... | Habitual abortion |
46 | Progesterone Depot ........... | Habitual abortion |
47 | Pyridostigmine Bromide ........ | Myasthenia gravis |
48 | Quinine Bisulphate ........... | Malaria |
49 | Quinine Dihydrochloride ....... | Malaria |
50 | Quinine Hydrochloride ........ | Malaria |
51 | Quinine Sulphate ............ | Malaria |
52 | Sodium Para-Aminosalicylate | Tuberculosis |
53 | Stilboestrol ................ | Carcinoma of the prostate Mammary carcinoma |
54 | Streptomycin ............... | Bacillary dysentery not responding to sulphonamides |
|
| Brucellosis |
|
| Chancroid |
|
| Endocarditis due to streptococcus faecalis |
|
| Endocarditis due to streptococcus viridans |
|
| Infections due to Friedlander bacillus |
|
| Infections due to haemophilus influenzae |
|
| Infections due to pseudomonas pyocyaneus |
|
| Plague |
|
| Rat-bite fever—streptobacillus moniliformis Salmonella infections |
|
| Surgical conditions of the bowel (pre-operative and post-operative) |
|
| Surgical conditions of the thoracic organs |
|
| Tuberculosis |
|
| Tularaemia |
|
| Urinary tract infections which do not respond to sulphonamides |
55 | Streptomycin Sulphate ......... | Any disease or purpose specified in this column in relation to streptomycin |
Second Schedule—continued.
Item No. | Name or Formula. | Disease or Purpose. |
56 | Suprarenal Cortex Extract ....... | Adrenal failure |
57 | Testosterone ............... | Mammary carcinoma |
|
| Castration |
58 | Testosterone Methyl .......... | Mammary carcinoma |
|
| Castration |
59 | Testosterone Oenanthate ....... | Mammary carcinoma |
|
| Castration |
60 | Testosterone Phenyl Propionate | Mammary carcinoma |
|
| Castration |
61 | Testosterone Propionate ........ | Mammary carcinoma |
|
| Castration |
62 | Tetracycline ................ | Any disease or purpose specified in this column in relation to chlortetracycline |
63 | Tetracycline with Oleandomycin | Any disease or purpose specified in this column in relation to chlortetracycline |
64 | Tetracycline with Sodium Meta-phosphate | Any disease or purpose specified in this column in relation to chlortetracycline |
65 | Tetracycline with Sodium Meta-phosphate (Suspension of) | The treatment of children under the age of 16 years in respect of any disease or purpose specified in this column in relation to chlortetracycline |
66 | Tretamine ................. | Malignant lymphoma and related conditions |
67 | Trimetaphan Camphor-sulphonate | Hypotensive for anaesthesia |
68 | Veriloid .................. | Hypertensive crisis |
69 | Vitamin K1 ................ | Antidote to anticoagulants |
By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra.